ACERAND THERAPEUTICS A
Live / Registered — Registered (as of 04 Jun 2024)
What this means for you
Registered since 04 Jun 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97839419
- Registration number
- 7405362
- Mark type
- Design + words
- Filed
- 15 Mar 2023
- Published for opposition
- 19 Mar 2024
- Registered
- 04 Jun 2024
- Attorney of record
- Charles Ho
Goods and services
- Class 042 — Scientific and technological services: Technological research in the field of developing pharmaceutical products; Scientific research; Chemical research; Pharmaceutical drug development; Product research and development for others; Scientific laboratory services; Development of pharmaceutical preparations and pharmaceuticals for the treatment of cancer, infection diseases, metabolic diseases, autoimmune diseases, central nervous system disorders, cardiovascular diseases and endocrine diseases; Pharmaceutical drug development services; Scientific research in the nature of conducting clinical trials for others in the field of cancer, infection diseases, metabolic diseases, autoimmune diseases, central nervous system disorders, cardiovascular diseases and endocrine diseases; Pharmaceutical research and development
Owner
- Acerand Therapeutics (Hong Kong) Limited, Hong Kong, HK
- Acerand Therapeutics (Hong Kong) Limited, Hong Kong, HK
- Acerand Therapeutics (Hong Kong) Limited, Hong Kong, HK
Prosecution history
- 04 Jun 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 04 Jun 2024 — REGISTERED-PRINCIPAL REGISTER
- 19 Mar 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Mar 2024 — PUBLISHED FOR OPPOSITION
- 28 Feb 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Feb 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 Feb 2024 — ELECTRONIC RECORD REVIEW COMPLETE
- 09 Feb 2024 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 02 Feb 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 Feb 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 31 Jan 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 31 Jan 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 19 Dec 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 19 Dec 2023 — NON-FINAL ACTION E-MAILED
- 19 Dec 2023 — NON-FINAL ACTION WRITTEN